Gene · 6783
Papers1,965
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,965
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Update and elucidation of Plasmodium kinomes: Prioritization of kinases as potential drug targets for malaria. | Comput Struct Biotechnol J | 2022 | 35891792 | PubTator, text mining | PubMed |
| Genome-Wide Association Study Identifies Multiple Susceptibility Loci for Malignant Neoplasms of the Brain in Taiwan. | J Pers Med | 2022 | 35887658 | PubTator, text mining | PubMed |
| Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine. | Int J Mol Sci | 2022 | 35887338 | PubTator, text mining | PubMed |
| Decreased DNA Damage and Improved p53 Specificity of RITA Analogs. | Mol Cancer Ther | 2022 | 35877475 | PubTator, text mining | PubMed |
| Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options. | Pharmacol Ther | 2022 | 35872332 | PubTator, text mining | PubMed |
| Gene regulation by histone-modifying enzymes under hypoxic conditions: a focus on histone methylation and acetylation. | Exp Mol Med | 2022 | 35869366 | PubTator, text mining | PubMed |
| A chromosome-level genome of the booklouse, Liposcelis brunnea, provides insight into louse evolution and environmental stress adaptation. | Gigascience | 2022 | 35852419 | PubTator, text mining | PubMed |
| Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA. | Front Toxicol | 2022 | 35832492 | PubTator, text mining | PubMed |
| 4″-Sulfation Is the Major Metabolic Pathway of Epigallocatechin-3-gallate in Humans: Characterization of Metabolites, Enzymatic Analysis, and Pharmacokinetic Profiling. | J Agric Food Chem | 2022 | 35786898 | PubTator, text mining | PubMed |
| Estetrol/Drospirenone: A Review in Oral Contraception. | Drugs | 2022 | 35781795 | PubTator, text mining | PubMed |
| Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression. | Cancer Metastasis Rev | 2022 | 35761157 | PubTator, text mining | PubMed |
| Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target. | Front Cardiovasc Med | 2022 | 35757325 | PubTator, text mining | PubMed |
| Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development. | Acta Pharm Sin B | 2022 | 35755285 | PubTator, text mining | PubMed |
| Triclosan: A Small Molecule with Controversial Roles. | Antibiotics (Basel) | 2022 | 35740142 | PubTator, text mining | PubMed |
| Nutritional deficiency in an intestine-on-a-chip recapitulates injury hallmarks associated with environmental enteric dysfunction. | Nat Biomed Eng | 2022 | 35739419 | PubTator, text mining | PubMed |
| Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges. | Clin Med Insights Oncol | 2022 | 35721387 | PubTator, text mining | PubMed |
| Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer. | Mol Med | 2022 | 35715741 | PubTator, text mining | PubMed |
| Ziritaxestat Drug-Drug Interaction with Oral Contraceptives: Role of SULT1E1 Inhibition. | Clin Pharmacol Ther | 2022 | 35713964 | PubTator, text mining | PubMed |
| Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences. | NPJ Breast Cancer | 2022 | 35697736 | PubTator, text mining | PubMed |
| Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways. | Front Immunol | 2022 | 35693820 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6783/papers?page=15